# Mitroflow DL Post Approval Study- North America

> **NCT02351726** · NA · TERMINATED · sponsor: **LivaNova** · enrollment: 186 (actual)

## Conditions studied

- Aortic Stenosis
- Aortic Regurgitation
- Aortic Valve Insufficiency
- Heart Valve Diseases
- Cardiovascular Abnormalities
- Cardiovascular Diseases
- Congenital Abnormalities
- Heart Diseases
- Pathological Conditions, Anatomical

## Interventions

- **DEVICE:** Mitroflow DL

## Key facts

- **NCT ID:** NCT02351726
- **Lead sponsor:** LivaNova
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-03
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 186 (ACTUAL)
- **Why stopped:** Sponsor business decision
- **Last updated:** 2020-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02351726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02351726, "Mitroflow DL Post Approval Study- North America". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02351726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*